Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-21 4:15 pm Purchase | 13D | ENGENE HLDGS INC ENGN | Lumira Capital Investment Management Inc. | 4,181,853 9.6% | 800,000 (+23.66%) | View |
| 2023-11-07 6:07 pm Purchase | 13D | ENGENE HLDGS INC ENGN | Lumira Capital Investment Management Inc. | 3,381,853 14.4% | 3,381,853 (New Position) | View |
| 2023-01-13 5:28 pm Sale | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 1,748,970 9% | -253,598 (-12.66%) | View |
| 2020-01-16 4:33 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 2,002,568 22.6% | 140,625 (+7.55%) | View |
| 2019-09-12 9:56 pm Sale | 13G | G1 THERAPEUTICS INC GTHX | Lumira Capital Investment Management Inc. | 1,124,012 2.995% | -430,325 (-27.69%) | View |
| 2019-08-19 5:05 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 1,861,943 24.8% | 101,606 (+5.77%) | View |
| 2019-06-17 3:38 pm Purchase | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 1,760,337 24.7% | 1,760,337 (New Position) | View |